Suppr超能文献

内质网应激在肥胖和胰岛素抵抗的高脂肪饮食喂养的 foz/foz 小鼠中不引起脂肪性肝炎。

Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.

机构信息

*Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.

†Liver Research Group, ANU Medical School at the Canberra Hospital, Garran, ACT, Australia.

出版信息

Clin Sci (Lond). 2014 Oct;127(7):507-18. doi: 10.1042/CS20140026.

Abstract

Non-alcoholic fatty liver (steatosis) and steatohepatitis [non-alcoholic steatohepatitis (NASH)] are hepatic complications of the metabolic syndrome. Endoplasmic reticulum (ER) stress is proposed as a crucial disease mechanism in obese and insulin-resistant animals (such as ob/ob mice) with simple steatosis, but its role in NASH remains controversial. We therefore evaluated the role of ER stress as a disease mechanism in foz/foz mice, which develop both the metabolic and histological features that mimic human NASH. We explored ER stress markers in the liver of foz/foz mice in response to a high-fat diet (HFD) at several time points. We then evaluated the effect of treatment with an ER stress inducer tunicamycin, or conversely with the ER protectant tauroursodeoxycholic acid (TUDCA), on the metabolic and hepatic features. foz/foz mice are obese, glucose intolerant and develop NASH characterized by steatosis, inflammation, ballooned hepatocytes and apoptosis from 6 weeks of HFD feeding. This was not associated with activation of the upstream unfolded protein response [phospho-eukaryotic initiation factor 2α (eIF2α), inositol-requiring enzyme 1α (IRE1α) activity and spliced X-box-binding protein 1 (Xbp1)]. Activation of c-Jun N-terminal kinase (JNK) and up-regulation of activating transcription factor-4 (Atf4) and CCAAT/enhancer-binding protein-homologous protein (Chop) transcripts were however compatible with a 'pathological' response to ER stress. We tested this by using intervention experiments. Induction of chronic ER stress failed to worsen obesity, glucose intolerance and NASH pathology in HFD-fed foz/foz mice. In addition, the ER protectant TUDCA, although reducing steatosis, failed to improve glucose intolerance, hepatic inflammation and apoptosis in HFD-fed foz/foz mice. These results show that signals driving hepatic inflammation, apoptosis and insulin resistance are independent of ER stress in obese diabetic mice with steatohepatitis.

摘要

非酒精性脂肪性肝病(脂肪变性)和脂肪性肝炎[非酒精性脂肪性肝炎(NASH)]是代谢综合征的肝脏并发症。内质网(ER)应激被认为是单纯脂肪变性肥胖和胰岛素抵抗动物(如 ob/ob 小鼠)中的关键疾病机制,但它在 NASH 中的作用仍存在争议。因此,我们评估了 ER 应激作为肥胖糖尿病伴有脂肪性肝炎的 foz/foz 小鼠疾病机制的作用。我们在几个时间点检测了 foz/foz 小鼠肝脏中的 ER 应激标志物对高脂肪饮食(HFD)的反应。然后,我们评估了用 ER 应激诱导剂衣霉素或相反地用 ER 保护剂牛磺熊脱氧胆酸(TUDCA)治疗对代谢和肝脏特征的影响。foz/foz 小鼠肥胖、葡萄糖不耐受,并在 HFD 喂养 6 周时发展为 NASH,其特征为脂肪变性、炎症、气球样肝细胞和细胞凋亡。这与未折叠蛋白反应的上游激活无关[磷酸化真核起始因子 2α(eIF2α)、肌醇需求酶 1α(IRE1α)活性和剪接 X 盒结合蛋白 1(Xbp1)]。然而,c-Jun N 端激酶(JNK)的激活和激活转录因子-4(Atf4)和 CCAAT/增强子结合蛋白同源蛋白(Chop)转录本的上调与 ER 应激的“病理性”反应一致。我们通过干预实验对此进行了测试。慢性 ER 应激的诱导未能加重肥胖、葡萄糖不耐受和 HFD 喂养的 foz/foz 小鼠的 NASH 病理。此外,尽管 ER 保护剂 TUDCA 降低了脂肪变性,但未能改善 HFD 喂养的 foz/foz 小鼠的葡萄糖不耐受、肝炎症和细胞凋亡。这些结果表明,在肥胖糖尿病伴有脂肪性肝炎的小鼠中,驱动肝炎症、细胞凋亡和胰岛素抵抗的信号与 ER 应激无关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验